Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination

AUTOR(ES)

Rambukkana, Anura

FONTE

National Academy of Sciences

RESUMO

Members of the arenavirus family, famous for their hemorrhagic syndromes, cause distinct neurological disorders; however, cellular and molecular targets as well as pathogenesis of peripheral nervous system disorders associated with these viruses are unknown. Using noncytolytic lymphocytic choriomeningitis virus, the prototype arenavirus, and pseudotyped Lassa fever virus, we showed that the Schwann cells, but not the neurons, were preferentially targeted and harbored the virus. This permissiveness was caused by the viral glycoprotein usage of its receptor α-dystroglycan, which was highly abundant on Schwann cell membranes. Persistent lymphocytic choriomeningitis virus infection rendered immature Schwann cells defective or incapable of forming compact myelin sheathes when they differentiated to myelinating phenotype in an in vitro differentiation model of Schwann cells. Persistent infection did not cause Schwann cell apoptosis or cytopathic effect. Defects in myelination coincided with the down-regulation of dystroglycan expression and disruption of the laminin-2 organization and basal lamina assembly on Schwann cell-axon units. The data provide evidence for a selective perturbation of laminin-2-laminin-2 receptor communication pathway in the peripheral nervous system by a nonlytic virus and the resulting myelin defects, which may partly contribute to neurological abnormalities associated with arenaviral infection.

Documentos Relacionados

• Deciphering peripheral nerve myelination by using Schwann cell expression profiling
• Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter
• Lupeol inhibits proliferation of human prostate cancer cells by targeting β-catenin signaling
• Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells.
• Properties of a persistent viral infection: possible lysogeny by an enveloped nonlytic mycoplasmavirus.